Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells

被引:0
|
作者
Edward Im
Friederike C von Lintig
Jeffrey Chen
Shunhui Zhuang
Wansong Qui
Shoaib Chowdhury
Paul F Worley
Gerry R Boss
Renate B Pilz
机构
[1] University of California,Department of Medicine and Cancer Center
[2] Johns Hopkins University,Department of Neuroscience
[3] Johns Hopkins University,Department of Neurology
来源
Oncogene | 2002年 / 21卷
关键词
Rheb; B-Raf kinase; MAP kinase; mammalian cells;
D O I
暂无
中图分类号
学科分类号
摘要
Rheb (Ras homolog enriched in brain) is a member of the Ras family of proteins, and is in the immediate Ras/Rap/Ral subfamily. We found in three different mammalian cell lines that Rheb was highly activated, to levels much higher than for Ras or Rap 1, and that Rheb's activation state was unaffected by changes in growth conditions. Rheb's high activation was not secondary to unique glycine to arginine, or glycine to serine substitutions at positions 14 and 15, corresponding to Ras residues 12 and 13, since Rheb R14G and R14G, S15G mutants had similarly high activation levels as wild type Rheb. These data are consistent with earlier work which showed that purified Rheb has similar GTPase activity as Ras, and suggest a relative intracellular deficiency of Rheb GTPase activating proteins (GAPs) compared to Rheb activators. Further evidence for relatively low intracellular GAP activity was that increased Rheb expression led to a marked increase in Rheb activation. Rheb, like Ras and Rap1, bound B-Raf kinase, but in contrast to Ras and Rap 1, Rheb inhibited B-Raf kinase activity and prevented B-Raf-dependent activation of the transcription factor Elk-1. Thus, Rheb appears to be a unique member of the Ras/Rap/Ral subfamily, and in mammalian systems may serve to regulate B-Raf kinase activity.
引用
收藏
页码:6356 / 6365
页数:9
相关论文
共 50 条
  • [1] Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
    Im, E
    von Lintig, FC
    Chen, J
    Zhuang, SH
    Qui, WS
    Chowdhury, S
    Worley, PF
    Boss, GR
    Pilz, RB
    ONCOGENE, 2002, 21 (41) : 6356 - 6365
  • [2] Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent
    Karbowniczek, M
    Cash, T
    Cheung, M
    Robertson, GP
    Astrinidis, A
    Henske, EP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) : 29930 - 29937
  • [3] Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization
    Karbowniczek, Magdalena
    Robertson, Gavin P.
    Henske, Elizabeth Petri
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) : 25447 - 25456
  • [4] Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation
    Trakul, N
    Menard, RE
    Schade, GR
    Qian, ZH
    Rosner, MR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) : 24931 - 24940
  • [5] Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants
    Koehler, Martin
    Roering, Michael
    Schorch, Bjoern
    Heilmann, Katharina
    Stickel, Natalie
    Fiala, Gina J.
    Schmitt, Lisa C.
    Braun, Sandra
    Ehrenfeld, Sophia
    Uhl, Franziska M.
    Kaltenbacher, Thorsten
    Weinberg, Florian
    Herzog, Sebastian
    Zeiser, Robert
    Schamel, Wolfgang W.
    Jumaa, Hassan
    Brummer, Tilman
    EMBO JOURNAL, 2016, 35 (02): : 143 - 161
  • [6] The synthesis of a novel inhibitor of B-Raf kinase
    Denni-Dischert, D
    Marterer, W
    Bänziger, M
    Yusuff, N
    Batt, D
    Ramsey, T
    Geng, P
    Michael, W
    Wang, RMB
    Taplin, F
    Versace, R
    Cesarz, D
    Perez, LB
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (01) : 70 - 77
  • [7] VEMURAFENIB B-raf Kinase Inhibitor Oncolytic
    Puzanov, I.
    Flaherty, K. T.
    Sosman, J. A.
    Grippo, J. F.
    Su, F.
    Nolop, K.
    Lee, R. J.
    Bollag, G.
    DRUGS OF THE FUTURE, 2011, 36 (03) : 191 - 199
  • [8] B-Raf kinase inhibitors for cancer treatment
    Li, Nanxin
    Batt, David
    Warmuth, Markus
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (06) : 452 - 456
  • [9] Development of potent inhibitors of B-Raf kinase
    Wei, Jianmei
    Wolin, Ronald
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [10] RKIP downregulates B-Raf kinase activity in melanoma cancer cells
    Park, S
    Yeung, ML
    Beach, S
    Shields, JM
    Yeung, KC
    ONCOGENE, 2005, 24 (21) : 3535 - 3540